Image – Interventional flashlight

DOI: 10.4244/EIJ-D-20-00511

Balloon aortic valvuloplasty with two simultaneous balloons via ipsilateral transradial and transbrachial access

Xavier Armario, MD; Liesbeth Rosseel, MB, BCh; Brian McGrath, BCh, MB, MD, PhD; Darren Mylotte

Figure 1. BAV with two simultaneous balloons via ipsilateral transradial and transbrachial access. A) Chronic type B aortic dissection extending from the left subclavian artery to the right iliofemoral artery: (a) severely calcified aortic valve; (b) aortic arch; (c) descending thoracic aorta; (d) right iliofemoral artery. Asterisk (*) indicates the true lumen. B) Patent right radial artery and occluded right ulnar artery (white arrow). C) Right brachial artery access. D) BAV with two simultaneous balloons. E) & F) Pre- and post-BAV invasive peak-to-peak gradient. BAV: balloon aortic valvuloplasty

Balloon aortic valvuloplasty (BAV) continues to play a role in the management of severe aortic stenosis (AS) in selected patients, either as a bridge to percutaneous or surgical aortic valve replacement or as a destination therapy. BAV is usually performed via transfemoral access but, when impossible, transradial approaches have been utilised - unilateral access with a single compliant balloon or bilateral access with two simultaneous peripheral balloons.

A frail 84-year-old male with severe AS presented with recurrent pulmonary oedema (Figure 1). He was declined surgical or transcatheter aortic valve replacement due to poor prognosis and an inoperable chronic type B aortic dissection extending from the left subclavian artery to the right iliofemoral artery. Palliative BAV was considered but aortic dissection precluded safe transfemoral or left transradial access. The intended strategy was therefore a simultaneous inflation of two 12 mm peripheral balloons (mean annulus diameter 26.8 mm on multislice computed tomography) via unilateral right radial and ulnar arterial access (7 Fr). However, the ulnar artery was occluded; a second access was achieved via an ultrasound-guided right brachial arterial puncture (vessel diameter 9.1 mm on ultrasound). Weight-adjusted unfractionated heparin was administered (activated clotting time [ACT] 330 sec), two Safari™ wires (Boston Scientific, Marlborough, MA, USA) were positioned in the left ventricle, and two 12 mm POWERFLEX® Pro balloons (Cordis, Miami Lakes, FL, USA) were simultaneously inflated under rapid ventricular pacing “on-the-wire”. The invasive peak-to-peak gradient decreased from 40 to 17 mmHg without an increase in aortic regurgitation. Protamine sulphate was administered (ACT 109 sec) and then compression haemostasis was used. Prolonged manual compression was needed for the brachial access. The patient was discharged on a direct oral anticoagulant due to atrial fibrillation and had no further admissions at three months.

This case demonstrates the feasibility of an ipsilateral approach for BAV with two simultaneous balloons in selected cases. Meticulous procedural planning and rigorous haemostasis management are crucial.

Conflict of interest statement

D. Mylotte is a consultant for Medtronic, Boston Scientific, and MicroPort, and declares personal fees from Medtronic, Boston Scientific, and MicroPort. The other authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 17 Number 1
May 16, 2021
Volume 17 Number 1
View full issue


Key metrics

Suggested by Cory

Tools and techniques

10.4244/EIJ-D-19-00074 Oct 4, 2019
Single-access balloon aortic valvuloplasty – an overview of contemporary technical improvements
Ooms J et al
free

Research correspondence

10.4244/EIJ-D-22-00798 Jun 5, 2023
Prophylactic intra-aortic balloon pump in transfemoral transcatheter aortic valve implantation
Scotti A et al
free

Flashlight

10.4244/EIJ-D-25-00341 Feb 2, 2026
Retrieval of a stuck transcatheter aortic valve device via left ventricular apex and transapical implantation
Yasuda M et al
open access
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved